Espansione’s eye-light combines intense pulsed light (IPL) with low-level light therapy (LLLT/photobiomodulation) to support the management of dry eye associated with meibomian gland dysfunction.
This combined approach is specifically featured in the Tear Film and Ocular Surface Society Dry Eye Workshop III (TFOS DEWS III) Management and Therapy report, which cites multiple studies using eye-light IPL and LLLT in patients with meibomian gland dysfunction (MGD).¹ The complementary technologies provide clinicians with a non-invasive, in-practice approach to managing tear film instability and evaporative dry eye beyond symptomatic lubrication alone. With growing clinical evidence supporting light-based therapies, eye-light provides an integrated platform for personalised, evidence-based chronic dry eye management.
Visit: ophthalmopro.com.au
References
- Jones L, Craig JP, Wolffsohn JS, et al. TFOS DEWS III: management and therapy. Am J Ophthalmol. 2025;279:289-386. doi: 10.1016/j.ajo.2025.05.039.
